The present invention provides a variant ActRIIB protein comprising an amino acid sequence that is at least 90% identical to amino acids 29-109 of SEQ ID NO:2, wherein the protein comprises an acidic amino acid at the position corresponding to position 79 of SEQ ID NO: 2.